We are live on
!
Find out more
Aspen Aerogels
ASPN
ASPN
Fund managers haven’t disclosed any holdings of ASPN yet.
ASPN Hedge Fund Activity: Q1 2026 in Review
166 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Aspen Aerogels (ASPN) for Q1 2026, worth a combined $237M — up 19% from $199M a quarter earlier.
Sellers outnumbered buyers: 49 funds closed out of ASPN and 34 opened new positions — a net loss of 15 holders — while 57 trimmed existing stakes and 44 added.
The largest buyer was Jacobs Levy Equity Management, adding an estimated $3.64M. The largest seller was Invesco, cutting an estimated $6.17M.
- 166 institutional investors held Aspen Aerogels (ASPN) as of Q1 2026, down from 183 in Q4 2025.
- Funds reported $237M of Aspen Aerogels stock for Q1 2026, up 19% quarter-over-quarter.
- 34 funds opened new Aspen Aerogels positions in Q1 2026 and 49 closed out, a net change of -15 holders.
- The largest Aspen Aerogels buyer in Q1 2026 was Jacobs Levy Equity Management, an estimated $3.64M added.
- The largest Aspen Aerogels seller in Q1 2026 was Invesco, an estimated $6.17M sold.
Based on aggregated 13F filings for Q1 2026.